7 Results for "

CA1 pyramidal neuron

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "CA1 pyramidal neuron" in MCE Product Catalog:

Cat. No.: HY-157786
CAS No.: 2230145-14-7
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

XPC-5462 is a selective NaV1.6/1.2 inhibitor, with an IC50 of 0.0103 μM against hNaV1.6, 0.0137 μM against mNaV1.6, and 0.0109 μM against hNaV1.2. XPC-5462 significantly reduces epileptiform discharges. XPC-5462 is applicable for epilepsy-related research .
loading...
    loading...
Cat. No.: HY-136980
CAS No.: 6157-06-8
Purity:  99.79%
Synonyms: Asp-Glu
Target:  

Endogenous Metabolite

Research Areas:  

Neurological Disease

Aspartylglutamate (Asp-Glu) is a dipeptide that exhibits excitatory activity, as it has been shown to depolarize CA1 pyramidal neurons and increase conductance in response to stimulation. Aspartylglutamate selectively binds to certain glutamate receptors and demonstrates potent effects in specific regions of the hippocampus, particularly in the stratum radiatum where it enhances excitatory neurotransmission.
loading...
    loading...
Cat. No.: HY-P4397
CAS No.: 115499-13-3
Target:  

Oxytocin Receptor

Research Areas:  

Endocrinology

(d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin, an oxytocin receptor antagonist, abolishes oxytocin-enhanced inhibitory postsynaptic currents in CA1 pyramidal neurons .
loading...
    loading...
Cat. No.: HY-100843
CAS No.: 78944-89-5
Target:  

Others

Research Areas:  

Neurological Disease

L-AP6 is a selective agonist for a quisqualate-sensitized site in hippocampal CA1 pyramidal neurons .
loading...
    loading...
Cat. No.: HY-117578
CAS No.: 131916-69-3
Target:  

Endogenous Metabolite

Research Areas:  

Neurological Disease

KB 5666 is a benzoxazine derivative with lipid peroxidation inhibitory activity. KB 5666 showed protective effects against post-ischemic neuronal death. KB 5666 effectively protected CA1 neurons when injected 5 minutes before or immediately after ischemia. KB 5666 also showed a dose-dependent protective effect when injected within 1 hour after ischemia. KB 5666 effectively prevented the significant decrease in microtubule-associated protein 2 immunoreactivity within the dendritic field of CA1 pyramidal cells. KB 5666 prevented the decrease in [3H]PDBu binding activity in different layers of the CA1 region after ischemia. The application of KB 5666 showed the ability to improve the cellular and functional consequences of ischemia .
loading...
    loading...
Cat. No.: HY-183101
CAS No.: 2163787-60-6
Target:  

iGluR NADPH Oxidase

Research Areas:  

Neurological Disease

AMPAR modulator-12 is a blood-brain barrier-permeable AMPAR positive allosteric modulator. AMPAR modulator-12 reduces NOX-1 expression, enhances AMPAR-mediated currents, promotes excitatory postsynaptic transmission and restores AMPAR function. AMPAR modulator-12 enhances excitatory and inhibitory synaptic transmission, reduces burst firing in the lateral habenula after withdrawal, and produces rapid and sustained antidepressant-like effects. AMPAR modulator-12 is applicable for the research of depression .
loading...
    loading...
Cat. No.: HY-182548
CAS No.: 165383-52-8
BTS 72664 is a broad-spectrum, non-sedating, orally effective anticonvulsant. Its anticonvulsant effect mainly arises from enhancing GABAA receptor (GABAA receptor)-mediated chloride channel currents, while it exerts weak blocking effects on Na + channels (Ki = 350 μM) and NMDA receptors (NMDA receptor) (IC50 = 43 μM). BTS 72664 prevents the elevation of extracellular glutamate, glycine and serine concentrations in neurons, reduces cerebral infarct size, promotes functional recovery, prevents multiple types of epileptic seizures, and has low sedative potential. BTS 72664 can be used for the research of epilepsy, stroke and migraine .
loading...
    loading...